The interest of preoperative lidocaine 2% nebulization among children with a cold undergoing ambulatory surgery : a randomized controlled trial
Phase 1
Not yet recruiting
- Conditions
- RespiratoryPaediatrics
- Registration Number
- PACTR202402589581256
- Lead Sponsor
- Hedi Chaker university hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
children aged 1 - 5 years with mild signs of upper respiratory tract infection
undergoning elective ambulatory ilio inguinal surgery
Exclusion Criteria
children with fever > 38 °C or ronchi
age < 1yo or > 5yo
patients whose parents did not consent to participate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie lidocaine's effect on upper respiratory tract infection in pediatric patients?
How does preoperative lidocaine nebulization compare to standard-of-care treatments for children with URI undergoing surgery?
Are there specific biomarkers that predict response to lidocaine nebulization in pediatric upper respiratory tract infections?
What are the known adverse events associated with lidocaine nebulization in children and how are they managed?
What are the potential combination approaches involving lidocaine for managing upper respiratory symptoms in pediatric surgery?